293 related articles for article (PubMed ID: 31461666)
1. Pathological pulses in PCOS.
Coyle C; Campbell RE
Mol Cell Endocrinol; 2019 Dec; 498():110561. PubMed ID: 31461666
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine control in polycystic ovary-like syndrome.
Schoemaker J
Gynecol Endocrinol; 1991 Dec; 5(4):277-88. PubMed ID: 1796749
[TBL] [Abstract][Full Text] [Related]
3. The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome.
Blank SK; McCartney CR; Marshall JC
Hum Reprod Update; 2006; 12(4):351-61. PubMed ID: 16670102
[TBL] [Abstract][Full Text] [Related]
4. Regulation of gonadotropin secretion: implications for polycystic ovary syndrome.
McCartney CR; Eagleson CA; Marshall JC
Semin Reprod Med; 2002 Nov; 20(4):317-26. PubMed ID: 12536355
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.
Blank SK; McCartney CR; Helm KD; Marshall JC
Semin Reprod Med; 2007 Sep; 25(5):352-9. PubMed ID: 17710731
[TBL] [Abstract][Full Text] [Related]
6. Pulsatile gonadotrophin secretion in women with polycystic ovary syndrome after gonadotrophin-releasing hormone agonist treatment.
Cheung AP; Lu JK; Chang RJ
Hum Reprod; 1997 Jun; 12(6):1156-64. PubMed ID: 9221993
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine aspects of polycystic ovary syndrome.
Marshall JC; Eagleson CA
Endocrinol Metab Clin North Am; 1999 Jun; 28(2):295-324. PubMed ID: 10352920
[TBL] [Abstract][Full Text] [Related]
8. Chronic androgen excess in female mice does not impact luteinizing hormone pulse frequency or putative GABAergic inputs to GnRH neurons.
Coyle CS; Prescott M; Handelsman DJ; Walters KA; Campbell RE
J Neuroendocrinol; 2022 Apr; 34(4):e13110. PubMed ID: 35267218
[TBL] [Abstract][Full Text] [Related]
9. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
Eagleson CA; Gingrich MB; Pastor CL; Arora TK; Burt CM; Evans WS; Marshall JC
J Clin Endocrinol Metab; 2000 Nov; 85(11):4047-52. PubMed ID: 11095431
[TBL] [Abstract][Full Text] [Related]
10. Reproductive neuroendocrine dysfunction in polycystic ovary syndrome: insight from animal models.
Roland AV; Moenter SM
Front Neuroendocrinol; 2014 Oct; 35(4):494-511. PubMed ID: 24747343
[TBL] [Abstract][Full Text] [Related]
11. Impaired steroid hormone feedback in polycystic ovary syndrome: Evidence from preclinical models for abnormalities within central circuits controlling fertility.
Moore AM
Clin Endocrinol (Oxf); 2022 Aug; 97(2):199-207. PubMed ID: 35349177
[TBL] [Abstract][Full Text] [Related]
12. Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions.
Pagán YL; Srouji SS; Jimenez Y; Emerson A; Gill S; Hall JE
J Clin Endocrinol Metab; 2006 Apr; 91(4):1309-16. PubMed ID: 16434454
[TBL] [Abstract][Full Text] [Related]
13. Use of a gonadotropin-releasing hormone antagonist as a physiologic probe in polycystic ovary syndrome: assessment of neuroendocrine and androgen dynamics.
Hayes FJ; Taylor AE; Martin KA; Hall JE
J Clin Endocrinol Metab; 1998 Jul; 83(7):2343-9. PubMed ID: 9661606
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of hypothalamic-pituitary-gonadal disruption in polycystic ovarian syndrome.
Barontini M; García-Rudaz MC; Veldhuis JD
Arch Med Res; 2001; 32(6):544-52. PubMed ID: 11750729
[TBL] [Abstract][Full Text] [Related]
15. Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
Pastor CL; Griffin-Korf ML; Aloi JA; Evans WS; Marshall JC
J Clin Endocrinol Metab; 1998 Feb; 83(2):582-90. PubMed ID: 9467578
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of a robust arcuate GABAergic input to gonadotropin-releasing hormone neurons in a model of polycystic ovarian syndrome.
Moore AM; Prescott M; Marshall CJ; Yip SH; Campbell RE
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):596-601. PubMed ID: 25550522
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic-pituitary, ovarian and adrenal contributions to polycystic ovary syndrome.
Baskind NE; Balen AH
Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():80-97. PubMed ID: 27137106
[TBL] [Abstract][Full Text] [Related]
18. Prenatal Androgen Exposure Alters KNDy Neurons and Their Afferent Network in a Model of Polycystic Ovarian Syndrome.
Moore AM; Lohr DB; Coolen LM; Lehman MN
Endocrinology; 2021 Nov; 162(11):. PubMed ID: 34346492
[TBL] [Abstract][Full Text] [Related]
19. Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood.
Tata B; Mimouni NEH; Barbotin AL; Malone SA; Loyens A; Pigny P; Dewailly D; Catteau-Jonard S; Sundström-Poromaa I; Piltonen TT; Dal Bello F; Medana C; Prevot V; Clasadonte J; Giacobini P
Nat Med; 2018 Jun; 24(6):834-846. PubMed ID: 29760445
[TBL] [Abstract][Full Text] [Related]
20. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle.
Lockwood GM; Muttukrishna S; Groome NP; Matthews DR; Ledger WL
J Clin Endocrinol Metab; 1998 May; 83(5):1730-5. PubMed ID: 9589683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
